Researchers are exploring the tantalizing prospect of identifying patients with kidney transplants who do not need to continue to take antirejection medicines to preserve their donated organ. At the very least, this line of research might enable physicians to recognize those patients with renal allografts who could take less immunosuppressive medicine, reducing the risks of infection and cancer associated with such drugs.
Mitka M. Some Studies Suggest Antirejection Drugs Not Always Needed to Protect Kidney Graft. JAMA. 2010;304(4):397. doi:10.1001/jama.2010.967
Customize your JAMA Network experience by selecting one or more topics from the list below.